As an experienced corporate attorney, Daniel regularly assists clients with corporate formation, corporate governance, and providing general advice on a company’s day-to-day operations, including drafting employment, consulting, and non-disclosure agreements, among others.

Daniel’s practice is also focused on drafting, reviewing, analyzing, structuring, and negotiating all types of complex commercial agreements specific to the life sciences industry, including pre-clinical agreements, clinical trial agreements, manufacturing agreements for commercial supply, licensing agreements, and various types of agreements with vendors, service providers, or outside parties including Master Services Agreements with Contract Research Organizations, services agreements with public and private institutions, and collaboration agreements.

Daniel is also experienced in transactional law, particularly in connection with drafting and negotiating complex M&A and financing transactions, including assisting clients on merger agreements, equity purchase agreements, asset acquisition agreements, share exchange agreements, and private financing transactions involving debt securities and equity financing. Daniel’s knowledge and experience in the civil law system, particularly in Mexico, helps him provide valuable cross-border transactional services to clients seeking to do business in the U.S. and Mexico (as well as other countries in Latin America). Daniel is the author of the whitepaper titled: “Beyond Earth’s Gravity: Navigating Legal Hurdles in Space-Based Drug Research and Development.”